Skip to main content
EDAP TMS SA logo

EDAP TMS SA — Investor Relations & Filings

Ticker · EDAP ISIN · US2683111072 US Manufacturing
Open in API
Filings indexed 464 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country US United States of America
Listing US EDAP

About EDAP TMS SA

https://focalone.com/fr/accueil/

EDAP TMS SA is a medical technology company that develops, manufactures, and distributes minimally invasive medical devices utilizing ultrasound technology. The company is a leader in robotic energy-based therapies, specializing in High-Intensity Focused Ultrasound (HIFU). Its flagship product is the Focal One®, an advanced robotic HIFU platform designed for the precise, non-invasive ablation of prostate tissue. The system enables urologists to target and destroy diseased tissue while preserving surrounding healthy structures, thereby minimizing side effects. Focal One integrates real-time ultrasound imaging with MRI and biopsy data fusion for accurate treatment planning and delivery, primarily for the focal treatment of prostate cancer.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 88% confidence The document is a U.S. SEC Form 8-K “Current Report” under Item 7.01 (Regulation FD Disclosure) and Item 9.01 Exhibits, announcing that an investor presentation slide deck (Exhibit 99.1) was presented and is attached. The text does not contain the actual financial presentation content but rather refers to the exhibit and provides regulatory reporting boilerplate. Per the “menu versus meal” rule, this is a short regulatory announcement of an attached report rather than the report itself. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-06-01 English
FORM 8-K
Regulatory Filings Classification · 78% confidence The document is a Form 8-K current report filed under the Securities Exchange Act of 1934 (an SEC regulatory filing). It provides “Other Events” disclosures (corporate name change, ticker symbol update, discontinued operations treatment, Investor Day details) and attaches a press release as Exhibit 99.1. It is not a full annual or interim report, not an earnings release, not a 10-K, not a proxy, not a dividend notice, nor a detailed investor presentation itself. It is a general regulatory announcement/fallback SEC filing, so it best fits the Regulatory Filings category (RNS).
2026-05-29 English
ARS
Annual Report FY 2025
2026-05-14 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-14 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-14 English
DEF 14A
Proxy Solicitation & Information Statement
2026-05-14 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.